Robert Caesar
University of Gothenburg(SE)
Publications by Year
Research Areas
Gut microbiota and health, Diet and metabolism studies, Liver Disease Diagnosis and Treatment, Adipokines, Inflammation, and Metabolic Diseases, Clostridium difficile and Clostridium perfringens research
Most-Cited Works
- → Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug(2017)1,590 cited
- → Dietary lipids, gut microbiota and lipid metabolism(2019)1,110 cited
- → Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling(2015)932 cited
- → Aberrant intestinal microbiota in individuals with prediabetes(2018)460 cited
- → Microbiota-induced obesity requires farnesoid X receptor(2016)453 cited
- → Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice(2012)326 cited
- → Microbiome and metabolome features of the cardiometabolic disease spectrum(2022)270 cited
- → Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism(2010)252 cited
- → Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status(2014)230 cited
- → Combinatorial, additive and dose-dependent drug–microbiome associations(2021)224 cited